96 publications
Name | Date | Type | Actions |
---|---|---|---|
[AUDIO] Présentation des résultats 2021 Présentation analystes & investisseurs - 24 mars 2022 |
Annual Report | ||
2008 activity report |
Annual Report | ||
2008 Annual earnings Operating highlights |
Annual Report | ||
2008 annual earnings The Vétoquinol Board of Directors, meeting on March 20, 2009, reviewed the group’s business and approved the group’s 2008 financial statements. |
Public releases | ||
2008 financial report Laboratoire pharmaceutique vétérinaire familial et indépendant, Vétoquinol se consacre exclusivement à la santé animale. Son activité est volontairement équilibrée entre animaux de rente et animaux de compagnie. |
Reference document | ||
2008 revenue: €234.4 M Revenue grew in 2008, despite poor economic conditions in the second half and |
Public releases | ||
2009 Revenue improvement in trends in the first quarter Vétoquinol’s revenue for the first quarter of 2009 reached €57.1 M, an increase of 4.4% over the first quarter of 2008. |
Public releases | ||
2010 calendar of financial communication December 7, 2009 (Lure, France) – Vétoquinol published its calendar of financial |
Agenda | ||
2021 Annual results ALL FINANCIAL INDICATORS UP. |
Public releases | ||
2022 HALF YEAR RESULTS Sales: €271m (up 6.0% as reported) |
Public releases |